Fig. 5. Subject (42 years/female) with dermal injection of HA-G in right nasolabial fold (NLF) and HA-P in left NLF. Genzyme 6-point grading scale changed.

Slides:

Advertisements

Similar presentations

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Advertisements

Gets ready to lead the way with a skin care breakthrough! A Dermatologist- grade hyaluronic acid facial filler - WITHOUT INJECTIONS!

CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.

AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.

Soft Tissue Fillers. What are Soft Tissue Fillers? injectable substances  Fat  Hyaluronic Acid  Calcium Hydroxylapatite improve the appearance of fine.

Fig. 16-CO, p Fig. 16-1, p. 450 Fig. 16-2, p. 450.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Hyaluronic (HA) Fillers

School. Answers to School Questions Question 7th grade Brediceanu 7th grade School No 2 5th grade School no 2 How many years of compulsory education do.

Read, Read, Read, Read, Read!! The following presentation is a review over important computer terms. They are important for you to recognize and understand.

Frequency of COP cells in control mice (caALK2) #1#2#3#4Average (%) Baseline (WT) undetectable Baseline (caALK2) 0.25 Day Day

Slide 1Fig 28-CO, p.858. Slide 2Fig 28-1, p.859 Slide 3Fig Q28-19, p.884.

WEEK 1 You have 10 seconds to name…

YOU CAN DISCOVER YOUR HIDDEN BEAUTY

Intra-articular Platelet Rich Plasma and Hyaluronic Acid are effective in Knee Osteoarthritis: A Comparative, Randomized Study Dr (Prof) Raju Vaishya MS(Ortho),FRCS,MCh.

Fig. 2. Clinical images of near total improvement cases. (A) No

Wrinkle Severity Rating Scale (WSRS) Training Slides

A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold.

Hyaluronic acid skin fillers: Adverse reactions and skin testing

Sonographic criteria for therapy follow-up in the course of ultrasound-guided intra- articular injections of hyaluronic acid in hand osteoarthritis Andrea.

Effects of hyaluronic acid (HA) viscosupplementation on peripheral Th cells in knee and hip osteoarthritis A. Lùrati, A. Laria, D. Mazzocchi, K.A. Re,

A case of cellulitis-like foreign body reaction after hyaluronic acid dermal filler injection Yo Sup Shin, Won Joo Kwon, Eun Byul Cho, Eun Joo Park, Kwang.

Fig. 2. Angiographic findings of a hyaluronic acid-injected patient

Fig. 4. Migration assays in neonatal normal human keratinocytes (NHKs) and human dermal fibroblasts (HDFs). NHKs (A) and HDFs (B) were cultured in either.

Fig. 4. Subject (61 years/female) with dermal injection of HA-P in right nasolabial fold (NLF) and HA-G in left NLF. Genzyme 6-point grading scale change.

Fig. 2. Histopathology findings of skin lesions

Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated.

Mesotherapy tested by Tokyo Clinic

Acne Scars B&A Pictures

All You Need To Know About Revanesse Filler

Tips On Buying Restylane Derma Fillers Online

Product Range Of Restylane Derma Fillers

Products Of Juvederm Dermal Fillers

The Secret Ingredient Of Juvederm Derma Fillers- Hyaluronic Acid The Juvederm Derma Fillers are made up of hyaluronic acid; it is a carbohydrate that builds.

Restylane Dermal Fillers Are Ultimate Solution

RADIESSE: THE FILLER YOU NEED FOR A REJUVENATED LOOK

The Teosyal RHA are Dynamic Fillers

Benefits Of Using Restylane

Diagram the pH scale Seconds Left:

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis Lorinda Chung, MD, David Fiorentino,

Efficacy of autologous platelet-rich plasma combined with hyaluronic acid on skin facial rejuvenation: A prospective study Barbara Hersant, MD, Mounia.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

End point Net change with soy supplements vs control (95% CI) p

A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid,

Steven D. Targum, Christopher J. Catania

Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review J.C. Fernández López, M.D., Ph.D.,

Diagram the pH scale Seconds Left:

Hyaluronic acid hydrogel functionalized with self-assembled micelles of amphiphilic pegylated kartogenin for the treatment of osteoarthritis M.-L. Kang,

Evaluation of the therapeutic effect of treatment with intra-articular hyaluronic acid in knees for Kashin-Beck disease: A meta-analysis F.F. Yu, C.T.

Quantitative MR T2 measurement of articular cartilage to assess the treatment effect of intra-articular hyaluronic acid injection on experimental osteoarthritis.

Volume 4, Issue 6, Pages (July 2018)

Anti-tumor effect of anti-PD-1 antibody against SCC3 tumor

Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis S. Fuchs, M.D., R. Mönikes, M.D., A. Wohlmeiner,

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study.

Effects of hyaluronic acid (HA) viscosupplementation on peripheral Th cells in knee and hip osteoarthritis A. Lùrati, A. Laria, D. Mazzocchi, K.A. Re,

Fig. 1. The treatment algorithm: In one treatment session, either a 595-nm pulsed-dye laser (PDL) or a non-ablative fractional laser (NAFL) was used. Additionally,

Fig. 2. Change in IPSS scores as a measure of treatment effectiveness

Fig. 3. Selective ophthalmic artery angiogram

Fig. 5. Skin changes after cosmetic facial filler injections on the glabella and/or nasal dorsum. (A-C) Hyaluronic acid-injected patients have skin necrosis.

Fig. 2. The pain score change in vitamin C group

Fig. 1. Wnt5a expression in psoriasis

Line graph showing mean (SEM) values for ankle pain on activity for intermittent and standard groups at baseline and week 1, 2, 3, 4, and 6 after injury.

Successful management of extreme pain from delayed embolization after hyaluronic acid filler injection Peter P. Rullan, MD, Kachiu C. Lee, MD, MPH JAAD.

Fig. 2. Axial contrast-enhanced T1-weighted subtraction MRI obtained 150 s after contrast injection in a 57-year-old post-menopausal woman treated for.

Fig. 4. Selective external carotid artery angiogram

Fig. 4. Immunohistochemistry showing difference in expression of galanin (GAL) and its receptors between lesional and normal skin. Galanin, GAL1R and GAL2R.

Presentation transcript:

Fig. 5. Subject (42 years/female) with dermal injection of HA-G in right nasolabial fold (NLF) and HA-P in left NLF. Genzyme 6-point grading scale changed from baseline to 24 weeks. Right: HA-G, 3.6 to 0.3; left: HA-P, 3 to 0.6. (A) Baseline, (B) 4 weeks, (C) 12 weeks, and (D) 24 weeks after treatment. HA: hyaluronic acid, HA-G, Glytone 3® (Merz Pharmaceuticals GmbH, Frankfurt, Germany); HA-P, Perlane® (Q-Med AB, Uppsala, Sweden). Fig. 5. Subject (42 years/female) with dermal injection of HA-G in right nasolabial fold (NLF) and HA-P in left NLF. Genzyme 6-point grading scale changed from baseline to 24 weeks. Right: HA-G, 3.6 to 0.3; left: HA-P, 3 to 0.6. (A) Baseline, (B) 4 weeks, (C) 12 weeks, and (D) 24 weeks after treatment. HA: hyaluronic acid, HA-G, Glytone 3® (Merz Pharmaceuticals GmbH, Frankfurt. . . Ann Dermatol. 2016 Jun;28(3):297-303. http://dx.doi.org/10.5021/ad.2016.28.3.297